Fennec Pharmaceuticals (FENC) Other Operating Expenses (2016 - 2025)

Fennec Pharmaceuticals' Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$10.5 million for Q4 2025.

• Quarterly Other Operating Expenses fell 1559.81% year-over-year to -$10.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.0 million (down 146.21% YoY) and the FY2025 annual result came in at $4.0 million, up 14.98% from the prior year.
• Other Operating Expenses was -$10.5 million for Q4 2025 at Fennec Pharmaceuticals, down from $689000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $5.8 million in Q1 2024 and bottomed at -$10.5 million in Q4 2025.
• A 4-year average of $532500.0 and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 595.56% in 2025, while the deepest fall reached 1559.81% in 2025.
• Fennec Pharmaceuticals' Other Operating Expenses stood at $2.8 million in 2022, then surged by 63.48% to $4.6 million in 2023, then plunged by 84.21% to $719000.0 in 2024, then plunged by 1559.81% to -$10.5 million in 2025.
• Business Quant data shows FENC's Other Operating Expenses at -$10.5 million in Q4 2025, $689000.0 in Q3 2025, and $5.3 million in Q2 2025.